Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Clinical trial NCT04270760 · COMPLETED

Trial details

NCT number: NCT04270760
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2020-07-28
Primary completion: 2021-12-27
Enrollment: 281

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.